Enhanced insulin signaling in density-enhanced phosphatase-1 (DEP-1) knockout mice

Molecular Metabolism

Volumn 4, Issue 4, 2015, Pages 325-336

  Krüger, Janine ^a   Brachs, Sebastian ^a   Trappiel, Manuela ^a   Kintscher, Ulrich ^a   Meyborg, Heike ^b   Wellnhofer, Ernst ^b   Thöne Reineke, Christa ^a   Stawowy, Philipp ^b   Östman, Arne ^c   Birkenfeld, Andreas L ^a   Böhmer, Frank D ^d   Kappert, Kai ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

^d JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Density enhanced phosphatase 1; Glucose homeostasis; Insulin resistance; Insulin signaling; Phosphorylation

Indexed keywords

DENSITY ENHANCED PHOSPHATASE 1; LEPTIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DOWN REGULATION; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; INSULIN SENSITIVITY; INSULIN SIGNALING; KNOCKOUT MOUSE; LIVER PARENCHYMA; MALE; MOUSE; MUSCLE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

MUS;

EID: 84924290214     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.02.001     Document Type: Article

References (50)

1. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
2. DeFronzo R.A. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 2010, 53:1270-1287.
3. Tikellis C., Pickering R., Tsorotes D., Du X.J., Kiriazis H., Nguyen-Huu T.P., et al. Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes. Clinical Science 2012, 123:519-529.
4. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
5. Bevan P. Insulin signalling. Journal of Cell Science 2001, 114:1429-1430.
6. Andersen J.N., Mortensen O.H., Peters G.H., Drake P.G., Iversen L.F., Olsen O.H., et al. Structural and evolutionary relationships among protein tyrosine phosphatase domains. Molecular and Cellular Biology 2001, 21:7117-7136.
7. Xu E., Charbonneau A., Rolland Y., Bellmann K., Pao L., Siminovitch K.A., et al. Hepatocyte-specific Ptpn6 deletion protects from obesity-linked hepatic insulin resistance. Diabetes 2012, 61:1949-1958.
8. Ahmad F., Azevedo J.L., Cortright R., Dohm G.L., Goldstein B.J. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. Journal of Clinical Investigation 1997, 100:449-458.
9. Ahmad F., Considine R.V., Bauer T.L., Ohannesian J.P., Marco C.C., Goldstein B.J. Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. Metabolism 1997, 46:1140-1145.
10. Bandyopadhyay D., Kusari A., Kenner K.A., Liu F., Chernoff J., Gustafson T.A., et al. Protein-tyrosine phosphatase 1B complexes with the insulin receptor invivo and is tyrosine-phosphorylated in the presence of insulin. Journal of Biological Chemistry 1997, 272:1639-1645.
11. Dubois M.J., Bergeron S., Kim H.J., Dombrowski L., Perreault M., Fournes B., et al. The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis. Nature Medicine 2006, 12:549-556.
12. Asante-Appiah E., Kennedy B.P. Protein tyrosine phosphatases: the quest for negative regulators of insulin action. American Journal of Physiology. Endocrinology and Metabolism 2003, 284:E663-E670.
13. Klaman L.D., Boss O., Peroni O.D., Kim J.K., Martino J.L., Zabolotny J.M., et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Molecular and Cellular Biology 2000, 20:5479-5489.
14. Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins S., Loy A.L., et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999, 283:1544-1548.
15. Galic S., Hauser C., Kahn B.B., Haj F.G., Neel B.G., Tonks N.K., et al. Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. Molecular and Cellular Biology 2005, 25:819-829.
16. Zabolotny J.M., Haj F.G., Kim Y.B., Kim H.J., Shulman G.I., Kim J.K., et al. Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. Journal of Biological Chemistry 2004, 279:24844-24851.
17. Goldstein B.J. Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance. Journal of Clinical Endocrinology & Metabolism 2002, 87:2474-2480.
18. Zabolotny J.M., Kim Y.B., Welsh L.A., Kershaw E.E., Neel B.G., Kahn B.B. Protein-tyrosine phosphatase 1B expression is induced by inflammation invivo. Journal of Biological Chemistry 2008, 283:14230-14241.
19. Owen C., Lees E.K., Grant L., Zimmer D.J., Mody N., Bence K.K., et al. Inducible liver-specific knockdown of protein tyrosine phosphatase 1B improves glucose and lipid homeostasis in adult mice. Diabetologia 2013, 56:2286-2296.
20. Ahmad F., Goldstein B.J. Alterations in specific protein-tyrosine phosphatases accompany insulin resistance of streptozotocin diabetes. American Journal of Physiology 1995, 268:E932-E940.
21. Zabolotny J.M., Kim Y.B., Peroni O.D., Kim J.K., Pani M.A., Boss O., et al. Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:5187-5192.
22. Ahmad F., Considine R.V., Goldstein B.J. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. Journal of Clinical Investigation 1995, 95:2806-2812.
23. Pandey S.K., Yu X.X., Watts L.M., Michael M.D., Sloop K.W., Rivard A.R., et al. Reduction of low molecular weight protein-tyrosine phosphatase expression improves hyperglycemia and insulin sensitivity in obese mice. Journal of Biological Chemistry 2007, 282:14291-14299.
24. Loh K., Merry T.L., Galic S., Wu B.J., Watt M.J., Zhang S., et al. Tcell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice. Diabetologia 2012, 55:468-478.
25. Ostman A., Yang Q., Tonks N.K. Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:9680-9684.
26. Senis Y.A., Tomlinson M.G., Ellison S., Mazharian A., Lim J., Zhao Y., et al. The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis. Blood 2009, 113:4942-4954.
27. Mori J., Wang Y.J., Ellison S., Heising S., Neel B.G., Tremblay M.L., et al. Dominant role of the protein-tyrosine phosphatase CD148 in regulating platelet activation relative to protein-tyrosine phosphatase-1B. Arteriosclerosis Thrombosis and Vascular Biology 2012, 32:2956-2965.
28. Kappert K., Paulsson J., Sparwel J., Leppanen O., Hellberg C., Ostman A., et al. Dynamic changes in the expression of DEP-1 and other PDGF receptor-antagonizing PTPs during onset and termination of neointima formation. FASEB Journal 2007, 21:523-534.
29. Palka H.L., Park M., Tonks N.K. Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1. Journal of Biological Chemistry 2003, 278:5728-5735.
30. Kovalenko M., Denner K., Sandstrom J., Persson C., Gross S., Jandt E., et al. Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1. Journal of Biological Chemistry 2000, 275:16219-16226.
31. Kruger J., Trappiel M., Dagnell M., Stawowy P., Meyborg H., Bohm C., et al. Targeting density-enhanced phosphatase-1 (DEP-1) with antisense oligonucleotides improves the metabolic phenotype in high-fat diet-fed mice. Cell Communication and Signaling 2013, 11:49.
32. Walchli S., Curchod M.L., Gobert R.P., Arkinstall S., Hooft van Huijsduijnen R. Identification of tyrosine phosphatases that dephosphorylate the insulin receptor. A brute force approach based on "substrate-trapping" mutants. Journal of Biological Chemistry 2000, 275:9792-9796.
33. Wang Q., Wang N., Dong M., Chen F., Li Z., Chen Y.Y. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice. Clinical Science 2014, 127:91-100.
34. Cartee G.D., Bohn E.E. Growth hormone reduces glucose transport but not GLUT-1 or GLUT-4 in adult and old rats. American Journal of Physiology 1995, 268:E902-E909.
35. Tsou R.C., Bence K.K. Central regulation of metabolism by protein tyrosine phosphatases. Frontiers in Neuroscience 2012, 6:192.
36. Delibegovic M., Bence K.K., Mody N., Hong E.G., Ko H.J., Kim J.K., et al. Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B. Molecular and Cellular Biology 2007, 27:7727-7734.
37. Owen C., Czopek A., Agouni A., Grant L., Judson R., Lees E.K., et al. Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis. PLoS One 2012, 7:e32700.
38. Delibegovic M., Zimmer D., Kauffman C., Rak K., Hong E.G., Cho Y.R., et al. Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress. Diabetes 2009, 58:590-599.
39. Tripathy D., Daniele G., Fiorentino T.V., Perez-Cadena Z., Chavez-Velasquez A., Kamath S., et al. Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study. Diabetologia 2013, 56:2153-2163.
40. Chen Z., Vigueira P.A., Chambers K.T., Hall A.M., Mitra M.S., Qi N., et al. Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor gamma-sparing thiazolidinedione. Journal of Biological Chemistry 2012, 287:23537-23548.
41. Barr A.J., Ugochukwu E., Lee W.H., King O.N., Filippakopoulos P., Alfano I., et al. Large-scale structural analysis of the classical human protein tyrosine phosphatome. Cell 2009, 136:352-363.
42. Bhaskar P.T., Hay N. The two TORCs and Akt. Developmental Cell 2007, 12:487-502.
43. Karlsson H.K., Zierath J.R., Kane S., Krook A., Lienhard G.E., Wallberg-Henriksson H. Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes 2005, 54:1692-1697.
44. Simonds S.E., Cowley M.A. Hypertension in obesity: is leptin the culprit?. Trends in Neurosciences 2013, 36:121-132.
45. Tsou R.C., Rak K.S., Zimmer D.J., Bence K.K. Improved metabolic phenotype of hypothalamic PTP1B-deficiency is dependent upon the leptin receptor. Molecular Metabolism 2014, 3:301-312.
46. Fischer K., Muller T.D. Relationship status update for PTP1B and LepR: its complicated. Molecular Metabolism 2014, 3:217-218.
47. Belin de Chantemele E.J., Ali M.I., Mintz J.D., Rainey W.E., Tremblay M.L., Fulton D.J., et al. Increasing peripheral insulin sensitivity by protein tyrosine phosphatase 1B deletion improves control of blood pressure in obesity. Hypertension 2012, 60:1273-1279.
48. Ainslie D.A., Proietto J., Fam B.C., Thorburn A.W. Short-term, high-fat diets lower circulating leptin concentrations in rats. American Journal of Clinical Nutrition 2000, 71:438-442.
49. Balavenkatraman K.K., Jandt E., Friedrich K., Kautenburger T., Pool-Zobel B.L., Ostman A., et al. DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients. Oncogene 2006, 25:6319-6324.
50. Trapasso F., Drusco A., Costinean S., Alder H., Aqeilan R.I., Iuliano R., et al. Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis. DNA and Cell Biology 2006, 25:376-382.